{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:22:18Z","timestamp":1787178138321,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:00:00Z","timestamp":1493942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS 31355"],"award-info":[{"award-number":["NS 31355"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS 41088"],"award-info":[{"award-number":["NS 41088"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["NIAAA -11865"],"award-info":[{"award-number":["NIAAA -11865"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorder and Stroke","doi-asserted-by":"crossref","award":["NS 38146"],"award-info":[{"award-number":["NS 38146"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11064-017-2280-2","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T22:32:46Z","timestamp":1493937166000},"page":"2755-2768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation"],"prefix":"10.1007","volume":"42","author":[{"suffix":"Jr.","given":"Lawrence G.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapan K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naren L.","family":"Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsankar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"2280_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278\u2013285","journal-title":"N Engl J Med"},{"key":"2280_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/FPC.0000000000000194","volume":"26","author":"E Tsareva","year":"2016","unstructured":"Tsareva E, Kulakova O, Boyko A, Favorova O (2016) Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs. Pharmacogenet Genom 26:103\u2013115","journal-title":"Pharmacogenet Genom"},{"key":"2280_CR3","first-page":"s141","volume":"22","author":"SF Hunter","year":"2016","unstructured":"Hunter SF (2016) Overview and diagnosis of multiple sclerosis. Am J Manag Care 22:s141\u2013s150","journal-title":"Am J Manag Care"},{"key":"2280_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B","volume":"45","author":"V Navikas","year":"1996","unstructured":"Navikas V, Link H (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45:322\u2013333","journal-title":"J Neurosci Res"},{"key":"2280_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0165-5728(00)00236-8","volume":"107","author":"G Martino","year":"2000","unstructured":"Martino G, Poliani PL, Furlan R et al (2000) Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach. J Neuroimmunol 107:184\u2013190","journal-title":"J Neuroimmunol"},{"key":"2280_CR6","doi-asserted-by":"publisher","first-page":"705232","DOI":"10.1155\/2013\/705232","volume":"2013","author":"N Deckx","year":"2013","unstructured":"Deckx N, Lee WP, Berneman ZN, Cools N (2013) Neuroendocrine immunoregulation in multiple sclerosis. Clin Dev Immunol 2013:705232","journal-title":"Clin Dev Immunol"},{"key":"2280_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/5532","volume":"5","author":"CP Genain","year":"1999","unstructured":"Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5:170\u2013175","journal-title":"Nat Med"},{"key":"2280_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0022-2275(20)31692-8","volume":"42","author":"S Dasgupta","year":"2001","unstructured":"Dasgupta S, Hogan EL (2001) Chromatographic resolution and quantitative assay of CNS tissue sphingoids and sphingolipids. J Lipid Res 42:301\u2013308","journal-title":"J Lipid Res"},{"key":"2280_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00019052-199906000-00011","volume":"12","author":"BC Kieseier","year":"1999","unstructured":"Kieseier BC, Storch MK, Archelos JJ, Martino G, Hartung HP (1999) Effector pathways in immune mediated central nervous system demyelination. Curr Opin Neurol 12:323\u2013336","journal-title":"Curr Opin Neurol"},{"key":"2280_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45","journal-title":"J Neuroinflammation"},{"key":"2280_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12017-010-8128-4","volume":"12","author":"A Jana","year":"2010","unstructured":"Jana A, Pahan K (2010) Sphingolipids in multiple sclerosis. Neuromolecular Med 12:351\u2013361","journal-title":"Neuromolecular Med"},{"key":"2280_CR12","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1046\/j.1471-4159.1996.66051986.x","volume":"66","author":"NR Bhat","year":"1996","unstructured":"Bhat NR, Zhang P (1996) Activation of mitogen-activated protein kinases in oligodendrocytes. J Neurochem 66:1986\u20131994","journal-title":"J Neurochem"},{"key":"2280_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.0.CO;2-0","volume":"54","author":"T Andrews","year":"1998","unstructured":"Andrews T, Zhang P, Bhat NR (1998) TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 54:574\u2013583","journal-title":"J Neurosci Res"},{"key":"2280_CR14","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1172\/JCI119114","volume":"98","author":"KA Krown","year":"1996","unstructured":"Krown KA, Page MT, Nguyen C et al (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98:2854\u20132865","journal-title":"J Clin Invest"},{"key":"2280_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF02527717","volume":"21","author":"LF Eng","year":"1996","unstructured":"Eng LF, Ghirnikar RS, Lee YL (1996) Inflammation in EAE: role of chemokine\/cytokine expression by resident and infiltrating cells. Neurochem Res 21:511\u2013525","journal-title":"Neurochem Res"},{"key":"2280_CR16","doi-asserted-by":"publisher","first-page":"979258","DOI":"10.1155\/2009\/979258","volume":"2009","author":"M Kunz","year":"2009","unstructured":"Kunz M, Ibrahim SM (2009) Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Med Inflamm 2009:979258","journal-title":"Med Inflamm"},{"key":"2280_CR17","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1152\/japplphysiol.00954.2007","volume":"104","author":"V Castellano","year":"2008","unstructured":"Castellano V, Patel DI, White LJ (2008) Cytokine responses to acute and chronic exercise in multiple sclerosis. J Appl Physiol 104:1697\u20131702","journal-title":"J Appl Physiol"},{"key":"2280_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12017-010-8135-5","volume":"12","author":"NJ Haughey","year":"2010","unstructured":"Haughey NJ (2010) Sphingolipids in neurodegeneration. Neuromolecular Med 12:301\u2013305","journal-title":"Neuromolecular Med"},{"key":"2280_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/BF02531040","volume":"4","author":"EA Moscatelli","year":"1969","unstructured":"Moscatelli EA, Isaacson E (1969) Gas liquid chromatographic analysis of sphingosine bases in sphingolipids of human normal and multiple sclerosis cerebral white matter. Lipids 4:550\u2013555","journal-title":"Lipids"},{"key":"2280_CR20","doi-asserted-by":"crossref","first-page":"S34D","DOI":"10.1046\/j.1471-4159.2000.0740034.x","volume":"74","author":"SS Dasgupta","year":"2000","unstructured":"Dasgupta S.S. et al (2000) Sphingolipid level in demyelinating disease. J. Neurochem 74:S34D","journal-title":"J. Neurochem"},{"key":"2280_CR21","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1074\/jbc.M109.076810","volume":"285","author":"J Qin","year":"2010","unstructured":"Qin J, Berdyshev E, Goya J, Natarajan V, Dawson G (2010) Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis. J Biol Chem 285:14134\u201314143","journal-title":"J Biol Chem"},{"key":"2280_CR22","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.21800","volume":"66","author":"AP Henderson","year":"2009","unstructured":"Henderson AP, Barnett MH, Parratt JD, Prineas JW (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66:739\u2013753","journal-title":"Ann Neurol"},{"key":"2280_CR23","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1002\/eji.201646485","volume":"46","author":"R Martin","year":"2016","unstructured":"Martin R, Sospedra M, Rosito M, Engelhardt B (2016) Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis. Eur J Immunol 46:2078\u20132090","journal-title":"Eur J Immunol"},{"key":"2280_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/A:1027324230923","volume":"32","author":"M Buntinx","year":"2003","unstructured":"Buntinx M, Vanderlocht J, Hellings N et al (2003) Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J Neurocytol 32:25\u201338","journal-title":"J Neurocytol"},{"key":"2280_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1385-299X(00)00027-1","volume":"5","author":"SK Ray","year":"2000","unstructured":"Ray SK, Schaecher KE, Shields DC, Hogan EL, Banik NL (2000) Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Protoc 5:305\u2013311","journal-title":"Brain Res Protoc"},{"key":"2280_CR26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-2275(20)37736-1","volume":"25","author":"H Igisu","year":"1984","unstructured":"Igisu H, Suzuki K (1984) Analysis of galactosylsphingosine (psychosine) in the brain. J Lipid Res 25:1000\u20131006","journal-title":"J Lipid Res"},{"key":"2280_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0006-8993(98)01128-7","volume":"816","author":"SK Ray","year":"1999","unstructured":"Ray SK, Shields DC, Saido TC et al (1999) Calpain activity and translational expression increased in spinal cord injury. Brain Res 816:375\u2013380","journal-title":"Brain Res"},{"key":"2280_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/0003-9861(84)90069-9","volume":"228","author":"RD Williams","year":"1984","unstructured":"Williams RD, Wang E, Merrill AH Jr (1984) Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys 228:282\u2013291","journal-title":"Arch Biochem Biophys"},{"key":"2280_CR29","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1074\/jbc.275.12.9078","volume":"275","author":"DK Perry","year":"2000","unstructured":"Perry DK, Carton J, Shah AK, Meredith F, Uhlinger DJ, Hannun YA (2000) Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275:9078\u20139084","journal-title":"J Biol Chem"},{"key":"2280_CR30","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1471-4159.2008.05451.x","volume":"106","author":"G Wang","year":"2008","unstructured":"Wang G, Krishnamurthy K, Chiang YW, Dasgupta S, Bieberich E (2008) Regulation of neural progenitor cell motility by ceramide and potential implications for mouse brain development. J Neurochem 106:718\u2013733","journal-title":"J Neurochem"},{"key":"2280_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/jnr.21214","volume":"85","author":"S Dasgupta","year":"2007","unstructured":"Dasgupta S, Yanagisawa M, Krishnamurthy K, Liour SS, Yu RK (2007) Tumor necrosis factor-alpha up-regulates glucuronosyltransferase gene expression in human brain endothelial cells and promotes T-cell adhesion. J Neurosci Res 85:1086\u20131094","journal-title":"J Neurosci Res"},{"key":"2280_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1194\/jlr.D600043-JLR200","volume":"48","author":"K Krishnamurthy","year":"2007","unstructured":"Krishnamurthy K, Dasgupta S, Bieberich E (2007) Development and characterization of a novel anti-ceramide antibody. J Lipid Res 48:968\u2013975","journal-title":"J Lipid Res"},{"key":"2280_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP (2010) Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 33:91\u2013101","journal-title":"Clin Neuropharmacol"},{"key":"2280_CR34","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1074\/jbc.M807438200","volume":"284","author":"S Lahiri","year":"2009","unstructured":"Lahiri S, Park H, Laviad EL, Lu X, Bittman R, Futerman AH (2009) Ceramide synthesis is modulated by the sphingosine analog FTY720 via a mixture of uncompetitive and noncompetitive inhibition in an Acyl-CoA chain length-dependent manner. J Biol Chem 284:16090\u201316098","journal-title":"J Biol Chem"},{"key":"2280_CR35","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1074\/jbc.M805186200","volume":"284","author":"EV Berdyshev","year":"2009","unstructured":"Berdyshev EV, Gorshkova I, Skobeleva A et al (2009) FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. J Biol Chem 284:5467\u20135477","journal-title":"J Biol Chem"},{"key":"2280_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000111201","volume":"19","author":"S Dasgupta","year":"1997","unstructured":"Dasgupta S, Everhart MB, Bhat NR, Hogan EL (1997) Neutral monoglycosylceramides in rat brain: occurrence, molecular expression and developmental variation. Dev Neurosci 19:152\u2013161","journal-title":"Dev Neurosci"},{"key":"2280_CR37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-2275(20)30117-6","volume":"43","author":"S Dasgupta","year":"2002","unstructured":"Dasgupta S, Levery SB, Hogan EL (2002) 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J Lipid Res 43:751\u2013761","journal-title":"J Lipid Res"},{"key":"2280_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.3101176","volume":"235","author":"YA Hannun","year":"1987","unstructured":"Hannun YA, Bell RM (1987) Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235:670\u2013674","journal-title":"Science"},{"key":"2280_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1158\/0008-5472.CAN-06-2374","volume":"67","author":"DC Phillips","year":"2007","unstructured":"Phillips DC, Martin S, Doyle BT, Houghton JA (2007) Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases. Cancer Res 67:756\u2013764","journal-title":"Cancer Res"},{"key":"2280_CR40","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1097\/00001756-199908020-00028","volume":"10","author":"I Plo","year":"1999","unstructured":"Plo I, Ghandour S, Feutz AC, Clanet M, Laurent G, Bettaieb A (1999) Involvement of de novo ceramide biosynthesis in lymphotoxin-induced oligodendrocyte death. Neuroreport 10:2373\u20132376","journal-title":"Neuroreport"},{"key":"2280_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139\u2013150","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2280_CR42","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1042\/bj3350465","volume":"335","author":"S Mathias","year":"1998","unstructured":"Mathias S, Pena LA, Kolesnick RN (1998) Signal transduction of stress via ceramide. Biochem J 335(3):465\u2013480","journal-title":"Biochem J"},{"key":"2280_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0014-5793(03)01168-2","volume":"554","author":"SW Paugh","year":"2003","unstructured":"Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S (2003) The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett 554:189\u2013193","journal-title":"FEBS Lett"},{"key":"2280_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1471-4159.2010.06644.x","volume":"114","author":"A Hoffmann","year":"2010","unstructured":"Hoffmann A, Grimm C, Kraft R et al (2010) TRPM3 is expressed in sphingosine-responsive myelinating oligodendrocytes. J Neurochem 114:654\u2013665","journal-title":"J Neurochem"},{"key":"2280_CR45","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1002\/jnr.21419","volume":"85","author":"S Dasgupta","year":"2007","unstructured":"Dasgupta S, Bhat NR, Spicer SS, Hogan EL, Furuya S, Hirabayashi Y (2007) Cell-specific expression of neutral glycosphingolipids in vertebrate brain: immunochemical localization of 3-O-acetyl-sphingosine-series glycolipid(s) in myelin and oligodendrocytes. J Neurosci Res 85:2856\u20132862","journal-title":"J Neurosci Res"},{"key":"2280_CR46","doi-asserted-by":"publisher","first-page":"20354","DOI":"10.1074\/jbc.273.32.20354","volume":"273","author":"I Singh","year":"1998","unstructured":"Singh I, Pahan K, Khan M, Singh AK (1998) Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem 273:20354\u201320362","journal-title":"J Biol Chem"},{"key":"2280_CR47","first-page":"492367","volume":"2015","author":"S Miyata","year":"2015","unstructured":"Miyata S, Hattori T, Shimizu S, Ito A, Tohyama M (2015) Disturbance of oligodendrocyte function plays a key role in the pathogenesis of schizophrenia and major depressive disorder. Biomed Res Int 2015:492367","journal-title":"Biomed Res Int"},{"key":"2280_CR48","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1148\/radiol.2441060930","volume":"244","author":"CS Yu","year":"2007","unstructured":"Yu CS, Zhu CZ, Li KC et al (2007) Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. Radiology 244:249\u2013256","journal-title":"Radiology"},{"key":"2280_CR49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1212\/WNL.45.3.478","volume":"45","author":"M Filippi","year":"1995","unstructured":"Filippi M, Campi A, Dousset V et al (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478\u2013482","journal-title":"Neurology"},{"key":"2280_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1468-1331.2001.00210.x","volume":"8","author":"M Filippi","year":"2001","unstructured":"Filippi M (2001) Linking structural, metabolic and functional changes in multiple sclerosis. Eur J Neurol 8:291\u2013297","journal-title":"Eur J Neurol"},{"key":"2280_CR51","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1093\/brain\/awn190","volume":"131","author":"D Wheeler","year":"2008","unstructured":"Wheeler D, Bandaru VV, Calabresi PA, Nath A, Haughey NJ (2008) A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 131:3092\u20133102","journal-title":"Brain"},{"key":"2280_CR52","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.4049\/jimmunol.1103109","volume":"188","author":"S Schiffmann","year":"2012","unstructured":"Schiffmann S, Ferreiros N, Birod K et al (2012) Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis. J Immunol 188:5723\u20135733","journal-title":"J Immunol"},{"key":"2280_CR53","first-page":"4906","volume":"19","author":"S Giacoppo","year":"2015","unstructured":"Giacoppo S, Soundara Rajan T, Galuppo M et al (2015) Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis. Eur Rev Med Pharmacol Sci 19:4906\u20134919","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2280_CR54","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.bbamem.2006.08.009","volume":"1758","author":"W Zheng","year":"2006","unstructured":"Zheng W, Kollmeyer J, Symolon H et al (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758:1864\u20131884","journal-title":"Biochim Biophys Acta"},{"key":"2280_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1432-1033.1991.tb16065.x","volume":"198","author":"EC Mandon","year":"1991","unstructured":"Mandon EC, van Echten G, Birk R, Schmidt RR, Sandhoff K (1991) Sphingolipid biosynthesis in cultured neurons. Down-regulation of serine palmitoyltransferase by sphingoid bases. Eur J Biochem 198:667\u2013674","journal-title":"Eur J Biochem"},{"key":"2280_CR56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/85879","volume":"27","author":"JL Dawkins","year":"2001","unstructured":"Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA (2001) Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 27:309\u2013312","journal-title":"Nat Genet"},{"key":"2280_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85817","volume":"27","author":"K Bejaoui","year":"2001","unstructured":"Bejaoui K, Wu C, Scheffler MD et al (2001) SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 27:261\u2013262","journal-title":"Nat Genet"},{"key":"2280_CR58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0022-510X(90)90022-F","volume":"100","author":"K Inui","year":"1990","unstructured":"Inui K, Nishimoto J, Taniike M et al (1990) Study of pathogenesis in twitcher mouse, an enzymatically authentic model of Krabbe\u2019s disease. J Neurol Sci 100:124\u2013130","journal-title":"J Neurol Sci"},{"key":"2280_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/08916939409008004","volume":"19","author":"M Matsuda","year":"1994","unstructured":"Matsuda M, Tsukada N, Koh CS, Iwahashi T, Shimada K, Yanagisawa N (1994) Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis. Autoimmunity 19:15\u201322","journal-title":"Autoimmunity"},{"key":"2280_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0022-510X(91)90219-W","volume":"104","author":"MP Pender","year":"1991","unstructured":"Pender MP, Nguyen KB, McCombe PA, Kerr JF (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104:81\u201387","journal-title":"J Neurol Sci"},{"key":"2280_CR61","doi-asserted-by":"publisher","first-page":"25843","DOI":"10.1074\/jbc.R200009200","volume":"277","author":"AH Merrill Jr","year":"2002","unstructured":"Merrill AH Jr (2002) De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem 277:25843\u201325846","journal-title":"J Biol Chem"},{"key":"2280_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamcr.2003.10.002","volume":"1643","author":"SG Meyer","year":"2003","unstructured":"Meyer SG, de Groot H (2003) Cycloserine and threo-dihydrosphingosine inhibit TNF-alpha-induced cytotoxicity: evidence for the importance of de novo ceramide synthesis in TNF-alpha signaling. Biochim Biophys Acta 1643:1\u20134","journal-title":"Biochim Biophys Acta"},{"key":"2280_CR63","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1159\/000341475","volume":"30","author":"T Kanno","year":"2012","unstructured":"Kanno T, Nishimoto T, Fujita Y, Gotoh A, Nakano T, Nishizaki T (2012) Sphingosine induces apoptosis in MKN-28 human gastric cancer cells in an SDK-dependent manner. Cell Physiol Biochem 30:987\u2013994","journal-title":"Cell Physiol Biochem"},{"key":"2280_CR64","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1194\/jlr.M022384","volume":"53","author":"C Ullio","year":"2012","unstructured":"Ullio C, Casas J, Brunk UT et al (2012) Sphingosine mediates TNFalpha-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells. J Lipid Res 53:1134\u20131143","journal-title":"J Lipid Res"},{"key":"2280_CR65","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/15216540600871118","volume":"58","author":"J Woodcock","year":"2006","unstructured":"Woodcock J (2006) Sphingosine and ceramide signalling in apoptosis. IUBMB Life 58:462\u2013466","journal-title":"IUBMB Life"},{"key":"2280_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1042\/bj3590335","volume":"359","author":"K Kagedal","year":"2001","unstructured":"Kagedal K, Zhao M, Svensson I, Brunk UT (2001) Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359:335\u2013343","journal-title":"Biochem J"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-017-2280-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-017-2280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T19:14:56Z","timestamp":1719170096000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-017-2280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2280"],"URL":"https:\/\/doi.org\/10.1007\/s11064-017-2280-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]},"assertion":[{"value":"26 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}